Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer

Schramm, Amelie; Schochter, Fabienne; Friedl, Thomas W. P.; de Greqorio, Nikolaus; Andergassen, Ulrich; Alunni-Fabbroni, Marianna; Trapp, Elisabeth; Jaeger, Bernadette; Heinrich, Georg; Camara, Oumar; Decker, Thomas; Ober, Angelika; Mahner, Sven; Fehm, Tanja N.; Pantel, Klaus; Fasching, Peter A.; Schneeweiss, Andreas; Janni, Wolfgang; Rack, Brigitte K.; SUCCESS Study Grp

Erstveröffentlichung

2017

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Schramm, Amelie

Schochter, Fabienne

Friedl, Thomas W. P.

de Greqorio, Nikolaus

Andergassen, Ulrich

et al.

Institutions

UKU. Klinik für Frauenheilkunde und Geburtshilfe

Published in

Clinical Breast Cancer ; 17 (2017), 4. - S. 279-285. - ISSN 1526-8209. - eISSN 1938-0666

Link to publication

https://dx.doi.org/10.1016/j.clbc.2016.11.008

Funding information

Pfizer
Sanofi-Aventis
Chugai
Janssen Diagnostics
AstraZeneca
etc.

Keywords

Adjuvant chemotherapy; Anthracyclines; Circulating tumor cells; HER2-negative early breast cancer; randomized-trial; premenopausal women; pooled analysis; her2 status; cyclophosphamide; fluorouracil; methotrexate; epirubicin; relevance; predicts

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record